Myasthenic Syndrome, Congenital, 15 (CMS15)

Myasthenic Syndrome, Congenital, 15(来自ICD-11)
别称:
Congenital Myasthenic Syndrome 15
Myasthenic Syndrome, Congenital, Without Tubular Aggregates
Cms15
Myasthenic Syndrome, Congenital, 15, Without Tubular Aggregates
Cmswta
Myasthenic Syndrome, Congenital, Type 15, Without Tubular Aggregates
Congenital Myasthenic Syndrome 15 Without Tubular Aggregates
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Myasthenic Syndrome, Congenital, 15, also known as congenital myasthenic syndrome 15, is related to myopathy, epilepsy, and progressive cerebral atrophy and congenital myasthenic syndromes with glycosylation defect. An important gene associated with Myasthenic Syndrome, Congenital, 15 is ALG14 (ALG14 UDP-N-Acetylglucosaminyltransferase Subunit), and among its related pathways/superpathways are Transport to the Golgi and subsequent modification and Diseases of glycosylation. Related phenotypes are fatigable weakness and emg: decremental response of compound muscle action potential to repetitive nerve stimulation
查看原文 参与反馈
相关ID:

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
AR
Unknown
--
10
65
2

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top